887 results on '"Solary E"'
Search Results
2. Moving toward precision oncology centers V2.0
3. Identification des mutations somatiques et analyse des mécanismes immunologiques au cours des manifestations auto-immunes et/ou inflammatoires associées à la leucémie myélomonocytaire chronique
4. Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation
5. Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease
6. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: CMML PATIENTS WITH LOW EXPRESSION OF TP53 POINT TO AML TRANSFORMATION
7. HETEROCHROMATIN CHANGES IN HSCS FROM CMML PATIENTS CONFER SENSITIVITY TO THE COMBINATION OF G9A/GLP INHIBITORS AND DNA HYPOMETHYLATING AGENTS VIA DEREPRESSION OF RETROELEMENTS
8. Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION
9. Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: CALPROTECTIN (S100A8/A9) EFFECTS ON HEALTHY CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS ARE AMPLIFIED IN CHRONIC MYELOID MALIGNANCIES
10. Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: CXCL8 SECRETED BY IMMATURE GRANULOCYTES INHIBITS WILD-TYPE STEM AND PROGENITOR CELL EXPANSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
11. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: IMPROVING THE CLONAL EVOLUTION MODEL: THE CASE OF CMML
12. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS OF THE BONE MARROW NICHE CONTRIBUTE TO THE PROINFLAMMATORY PHENOTYPE OF CMML MONOCYTES THROUGH IGFBP2
13. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA
14. P098 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA
15. P084 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS OF THE BONE MARROW NICHE CONTRIBUTE TO THE PROINFLAMMATORY PHENOTYPE OF CMML MONOCYTES THROUGH IGFBP2
16. P079 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: CXCL8 SECRETED BY IMMATURE GRANULOCYTES INHIBITS WILD-TYPE STEM AND PROGENITOR CELL EXPANSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
17. P062 - Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: CMML PATIENTS WITH LOW EXPRESSION OF TP53 POINT TO AML TRANSFORMATION
18. P057 - Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION
19. P044 - Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: IMPROVING THE CLONAL EVOLUTION MODEL: THE CASE OF CMML
20. P036 - Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: CALPROTECTIN (S100A8/A9) EFFECTS ON HEALTHY CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS ARE AMPLIFIED IN CHRONIC MYELOID MALIGNANCIES
21. O15 - HETEROCHROMATIN CHANGES IN HSCS FROM CMML PATIENTS CONFER SENSITIVITY TO THE COMBINATION OF G9A/GLP INHIBITORS AND DNA HYPOMETHYLATING AGENTS VIA DEREPRESSION OF RETROELEMENTS
22. The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
23. Developmental changes in human megakaryopoiesis
24. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
25. Quinine Improves Results of Intensive Chemotherapy (IC) in Myelodysplastic Syndromes (MDS) Expressing P-Glycoprotein (PGP) : Updated Results of a Randomized Study
26. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
27. Mitoxantrone/Cytarabine with or without Quinine as a Potential MDR- Reversing Agent for the Treatment of Acute Leukemias
28. cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
29. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
30. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
31. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
32. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
33. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
34. Caspases/NOX2 axis: a potential target to modulate macrophage polarization: 6.72
35. Intensive Therapy of Myelodysplastic Syndromes and Secondary Leukemias: Preliminary Findings of the French Experience
36. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
37. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
38. An evolutionary perspective on chronic myelomonocytic leukemia
39. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
40. Identifying key questions in the ecology and evolution of cancer
41. JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
42. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells
43. The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism
44. ASXL1andSETBP1mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
45. Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
46. Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
47. Mutation du gène UBA1 dans l’artérite à cellules géantes
48. Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells
49. Mitochondria in hematopoiesis and hematological diseases
50. Cellular localisation of Survivin: impact on the prognosis in colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.